Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harnisha Dalwadi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Research|September 18, 2004
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancerKostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, et al.
Infection and Immunity|November 20, 2002
Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigenBo Wei, Tiffany Huang, Harnisha Dalwadi, et al.
Cancer Research|July 19, 2005
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent mannerKostyantyn Krysan, Karen L Reckamp, Harnisha Dalwadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
B cell developmental requirement for the G alpha i2 geneHarnisha Dalwadi, Bo Wei, Matthew Schrage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancerHarnisha Dalwadi, Kostyantyn Krysan, Nathalie Heuze-Vourc'h, et al.
International Immunology|October 21, 2003
TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naïve CD4(+) T cell disorder selective for the Galphai2 subunitTiffany T Huang, Yumei Zong, Harnisha Dalwadi, et al.
Clinical Lung Cancer|August 16, 2005
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancerJenny T Mao, Xiaoyan Cui, Karen Reckamp, et al.
European Journal of Immunology|November 15, 2008
Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cellsBo Wei, Thomas T Su, Harnisha Dalwadi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 7, 2004
Multifaceted roles of cyclooxygenase-2 in lung cancerKaren Riedl, Kostyantyn Krysan, Mehis Põld, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
IL-20, an anti-angiogenic cytokine that inhibits COX-2 expressionNathalie Heuzé-Vourc'h, Ming Liu, Harnisha Dalwadi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Research|September 18, 2004
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancerKostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, et al.
Infection and Immunity|November 20, 2002
Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigenBo Wei, Tiffany Huang, Harnisha Dalwadi, et al.
Cancer Research|July 19, 2005
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent mannerKostyantyn Krysan, Karen L Reckamp, Harnisha Dalwadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
B cell developmental requirement for the G alpha i2 geneHarnisha Dalwadi, Bo Wei, Matthew Schrage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancerHarnisha Dalwadi, Kostyantyn Krysan, Nathalie Heuze-Vourc'h, et al.
International Immunology|October 21, 2003
TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naïve CD4(+) T cell disorder selective for the Galphai2 subunitTiffany T Huang, Yumei Zong, Harnisha Dalwadi, et al.
Clinical Lung Cancer|August 16, 2005
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancerJenny T Mao, Xiaoyan Cui, Karen Reckamp, et al.
European Journal of Immunology|November 15, 2008
Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cellsBo Wei, Thomas T Su, Harnisha Dalwadi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 7, 2004
Multifaceted roles of cyclooxygenase-2 in lung cancerKaren Riedl, Kostyantyn Krysan, Mehis Põld, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
IL-20, an anti-angiogenic cytokine that inhibits COX-2 expressionNathalie Heuzé-Vourc'h, Ming Liu, Harnisha Dalwadi, et al.
Pageof 1